Catalyst
Slingshot members are tracking this event:
Phase 2a data of Global Blood Therapeutics's(GBT) GBT440 in Hypoxemia in patients with idiopathic pulmonary fibrosis (IPF) who are on supplemental oxygen at rest expected Q4 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GBT | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 23, 2017
Occurred Source:
http://ir.globalbloodtx.com/phoenix.zhtml?c=254105&p=irol-newsArticle&ID=2310284
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2a, Gbt440, Hypoxemia, Idiopathic Pulmonary Fibrosis
